Navigation Links
Versailles Group Announces Accentus, Inc. Acquired by High Road Capital Partners
Date:4/21/2009

BOSTON, April 21 /PRNewswire/ -- Versailles Group, Ltd. (http://www.versaillesgroup.com) announced today Accentus, Inc. (http://www.accentus.ca) has been acquired by High Road Capital Partners (http://www.highroadcap.com) of New York.

Based in Ottawa, Ontario, Accentus is the largest provider in the Canadian outsourced medical transcription industry. Accentus provides medical transcription and editing services to over half of all hospitals, clinics, and independent physician groups throughout Canada.

Versailles Group, a 22-year-old Boston-based investment bank that specializes in international mergers, acquisitions, and divestitures, advised Accentus' shareholders on the transaction. Versailles Group has worked with companies in the U.S., Europe, Canada, and Latin America.

"With more than two decades of experience, Versailles Group is the expert in finding the right buyer for its domestic and international clients," said Don Grava, founder and president. "We are pleased that we successfully did so for Accentus."

"Accentus has been a leader in its industry for nearly a decade," he said. "When owners Steve and Rod Rogers retained Versailles Group for their divestiture, they knew that the combination of Versailles Group's skill and Accentus' performance would net them a superior valuation and a successful transaction. The clients' expectations were surpassed."

Versailles Group had previously sold two other businesses for the Rogers Family, Taima Corporation to Convergys Corporation and The PSC Communications Group Inc. to MacDonald Dettwiler & Associates.

Stephen Rogers, CEO of Accentus, and a significant investor in the divestiture along with brother and president Roderick Rogers, said, "Accentus has played a key role in developing the market for outsourced medical transcription and editing services in Canada." Rogers said that he and his brother "saw tremendous opportunity to accelerate Accentus' growth in partnership with High Road while continuing to provide exceptional service to our customers."

Senior debt financing for the transaction was provided by Bank of Montreal. Subordinated debt financing was provided by Bank of Montreal Capital Corporation, which invested along with High Road and Accentus management.

Transaction consideration was not disclosed.

Versailles Group, Ltd.

Versailles Group, Ltd. is a Boston-based investment bank that specializes in international mergers, acquisitions, and divestitures. Versailles Group's skill, flexibility, and experience have enabled it to successfully close transactions in any economic environment. More information on Versailles Group can be found on its website, http://www.versaillesgroup.com.

    For more information:

    Donald Grava (617) 449-3325
    dgrava@versaillesgroup.com

This release was issued through eReleases(TM). For more information, visit http://www.ereleases.com.


'/>"/>
SOURCE Versailles Group, Ltd.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Broad-based group of physicians calls for improvement in stroke treatment
2. CRC Health Group Announces Acquisition of Bayside Marin Recovery Center, San Rafael
3. CIGNA Group Insurance Shows Consumers Theres More to Life Through a New Consumer Education Toolkit
4. HIDA Calls for Scrutiny of Group Purchasing Organization Distributor Fee Structure
5. New Research Uncovers how to Build and Maintain an Effective Competitive Intelligence Group
6. AMERIGROUP to Acquire Memphis Health Plan
7. Securians Minnesota Life Continues to Climb Group Life Rankings
8. Dr. Allen Woolf Appointed Chief Medical Officer For CIGNA Group Insurance
9. Are Bargaining Groups Hired by Independent Drugstores Causing Payment Delays to Pharmacies?
10. Group B Strep: A Threat to Newborns That Doesnt Have to Be
11. Cynosure to Present at the Maxim Group Growth Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/22/2017)... San Ramon, CA (PRWEB) , ... March 22, ... ... and tissue recovery agency for northern California and Nevada and LABS, Inc., announced ... in rapid turnaround (STAT) infectious disease screening and serology testing used to ...
(Date:3/22/2017)... ... March 22, 2017 , ... The Rett Syndrome Research ... neurological disorder that afflicts 350,000 individuals worldwide. Rett Syndrome is caused by ... exclusively strikes females. Following a normal infancy, Rett Syndrome takes effect in ...
(Date:3/22/2017)... ... March 22, 2017 , ... The Burke Medical Research Institute ... advances in basic neuroscience at the BMRI labs into new and improved treatments ... movement, vision, and cognition impaired by stroke, traumatic brain injury, cerebral palsy, and ...
(Date:3/22/2017)... ... March 22, 2017 , ... SNL Insurance and ... families and business owners in the greater Hampton Roads area, is embarking on ... Relay For Life event. , Each year, hundreds of people living in the ...
(Date:3/22/2017)... ... ... Schneider Insurance and Financial, a southern Montana firm providing asset protection and ... launching a charity event aimed at raising local support for Zoo Montana. , Zoo ... is home to a broad variety of animals from all over the world. Many ...
Breaking Medicine News(10 mins):
(Date:3/22/2017)...  ImaginAb Inc. today announced the appointment of Martyn Coombs ... , chairman of ImaginAb, said "At ImaginAb we have exciting science ... relevant to our business, particularly in commercializing and making step changes ... we can realize our potential." ... Mr. Coombs is a recognized industry leader in nuclear ...
(Date:3/22/2017)... 2017 Research and Markets has announced ... Market & Clinical Pipeline Insight 2022" drug pipelines to ... ... Pipeline Insight 2022 report gives comprehensive insight on clinical and ... check point inhibitors as main streamline drugs in the immunotherapy ...
(Date:3/22/2017)... LINCOLN, Mass. , March 22, 2017 /PRNewswire/ ... applying mechanistic modeling to drug research and development, ... QSP Day 2017.  QSP Day 2017 is a ... with the quantitative systems pharmacology (QSP) community. The ... mathematical modeling is de-risking and accelerating drug research ...
Breaking Medicine Technology: